Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Matt Costa is our new Professor of Orthopaedic Trauma.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is pleased to welcome Professor Matt Costa to the department, joining from 11 May 2015 as Professor of Orthopaedic Trauma Surgery.

Matt is an internationally recognised clinical academic in orthopaedic trauma , as well as having his own clinical practice in trauma surgery. He joins us from the Warwick Clinical Trials Unit, where until recently he was Professor of Trauma and Orthopaedics.

Matt’s research interest is in clinical and cost effectiveness of musculoskeletal interventions, as well as clinical trials and trial design.

Speaking of his appointment, Professor Costa said: “I’m very excited to be joining the team at NDORMS. Musculoskeletal trauma is a huge issue for patients, the NHS and society more broadly. There are so many areas where we can improve patient care and there is no where in the world better placed to address this need than Oxford. I can’t wait to start at NDORMS and look forward to working with the world-leading academics at the University and the world-leading surgeons at the John Radcliffe Hospital”.

Professor Andrew Carr, Head of NDORMS welcomed Professor Costa and said: "I am delighted that Professor Matt Costa is joining the department. He has an international reputation in surgical trials of trauma and will add significantly to research in this area”.

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.